Exagen works with diagnostic companies to discover and develop new assays in their areas of disease focus. Coperna® is used to identify the set (s) of biomarkers in genome-wide data. These markers are then transferred to the laboratory format most appropriate for your targeted customers. Our goal is to work as a team to develop tests that are a key to diagnosing, treating, and monitoring, and providing better patient care.

For more information about Exagen's capabilities in this area, please contact: BusinessDevelopment@exagen.com 866.392.4361